The post-translational modifications (farnesylation, proteolysis and carboxyl methylation) of p21ras proteins are required to promote plasma membrane association1}. This localization is essential for the transforming activity induced by ras oncogenes. Inhibition of p21ras farnesylation has therefore been suggested as a potential strategy for antitumour chemotherapy research2). During our screening for farnesyl-protein transferase (FPTase) inhibitors of microbial origin, we have discovered a novel compound: RPR113228 isolated from the fermentation broth of a fungus. We herein report the production, isolation, structure elucidation and inhibitory activities of this secondary metabolite. The producing strain was isolated from a soil sample. Arrows indicate long range correlations observed on 2D HMBC experiment.
This article is a special contribution in honour of Professor Satoshi Omura's 60th birthday. The molecular formula was established as C30H49O9P by HMBC experiment, which have been used for structure elucidation (Fig. 2) . The *H and 13C assignments deducted from 2D NMRexperiments are given in 737 This secondary metabolite represents a novel potent inhibitor of Ras post-translational processing that might be useful as anticancer agent particularly in colon and pancreatic carcinomas.
